Global E-Waste Management Market (2011 – 2016)

Published: August 2011

Price: $ 4650

Rapid advancement in technology is resulting in new electronic products being launched, along with upgraded versions of existing products such as laptops and mobile phones flooding the market on a regular basis. This, coupled with an increase in the buying power of individuals, is resulting in decrease in the shelf life of electronic products. This trend is causing an accumulation of electronic waste that triggers the need to recycle electronic products; which implies the fact that the recycling industry will always have its share in the market.

Developing countries such as India, China, and countries in Africa are facing the heat of the e-waste being illegally dumped in these countries from the developed countries such as U.S and UK. Most of these electronic products are simply plonked in these countries since no facilities exist for safe recycling of these products.

Browse All: Semiconductor Market

It is in the recent past that the countries have realized the need to efficiently recycle all the components of the electronic products and reuse them. The recycling rates of various components are very low, for e.g., out of the plastic generated from the electronic products, approximately only five percent of it is recycled. There is an increasing demand for proper e-waste management techniques since e-waste consists of toxic materials, which if not properly disposed, can lead to high levels of pollution. Such pollution, if not controlled, can lead to irreversible damage to human health as well as the environment.

The EU mandated all the producers of electronics to undertake the responsibility of disposal of end-of-life products. These regulations are encouraging companies to “recycle and reuse” the products. Some of the regulations in the European Union are the WEEE directive, RoHS, and Basel Convention.

The report deals with the market trends in the e-waste management market, the gap between the volume of e-waste generated and currently being recycled, and the amount that is expected to be recycled in the next five years.

The global volume of e-waste generated is expected to reach 93.5 million tons in 2016 from 41.5 million tons in 2011 at a CAGR of 17.6% from 2011 to 2016. The revenue generated from the e-waste management market is expected to grow from $9.15 billion in 2011 to $20.25 billion in 2016 at a CAGR of 17.22% from 2011 to 2016.

Scope of the report

This research report categorizes the global e-waste management market on the basis of different materials used in the electronic products, the source from where e-waste is generated, and includes geographical analysis, forecasting revenues, and analyzing trends in the e-waste management market.

On the basis of material recovery market

The materials such as plastic, glass, metals and other materials used in the electronic products, and the percentage of every material present in some of the electronic equipment are discussed.

On the basis of source market

The source of the generation of e-waste is discussed with the amount of every component being used in the electronic product and hence the amount of waste that is generated from specific electronic products.

On the basis of geography

• North America, Europe, Asia-Pacific, and ROW are covered in the report.

• North America is subdivided into U.S., Canada, and Mexico

• Europe is further divided into UK, Germany, France, and others

• Asia-Pacific is divided into China, India, Japan, and others

• ROW is segmented into Africa, Middle East, and others

Each section will provide market data, market drivers, trends and opportunities, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, the report also provides more than 20 company profiles covering all the sub-segments.

Carbon Fiber Market by Types, Applications, Trends & Global Forecasts (2011 – 2016)

Published: August 2011
Price: $ 4650

Carbon fiber has remarkable properties such as tensile strength, stiffness, low density, electrical conductivity, and chemical inertness; which makes it an ideal material to be used in a number of applications in several industries such as aerospace, wind energy, automotive, industrial applications, and sporting goods.

Historically, carbon fiber industry has been cyclical with a period of limited supply resulting in high prices to periods of oversupply & falling prices. However, the market has experienced excellent growth recently. The growth rate for the last 23 years averaged about 12%. Rapid increase in demand for carbon fiber for newer applications such as wind energy and industrial applications are said to drive the market further in the years to come.

Browse All: Advanced Materials Market Research

Though the carbon fiber has been around for more than three decades now, it is still far from being commercialized. It is still a niche industry with some amount of mass usage in aerospace industry; but in the other industries, there is still a long way to go. The cost of the carbon fiber varies from application to application, aerospace grade carbon fiber being the most expensive among the available variety. The main hindrance for commercialization is the current cost of the carbon fiber that is very high due to the soaring cost of the raw material that is currently being used and also the processing methods that are highly energy consuming.

There is currently a pressing need to improve vehicle fuel efficiency, industrial energy efficiency, and to produce energy through renewable sources across the globe. The answer to these problems currently lies in using stiffer & lighter carbon fiber in place of traditional metals. Department of Energy (U.S.) and government of Japan have invested heavily in developing materials and technologies for the production of low-cost carbon fiber. If they succeed, there will be a revolution in the carbon fiber industry; especially in automotive arena.

This market research study Carbon Fiber Market by Types, Applications, Trends & Global Forecasts (2011 – 2016) provides detailed qualitative and quantitative analysis of the carbon fiber market. It gives the current market size & individual forecasts for PAN-based or pitch-based carbon fiber. It further classifies PAN-based market into sub categories such as small-tow & large-tow and provides current & future market data for these categories. In addition, it probes in detail into each applications market and provides separate forecasts for aerospace, wind energy, automotive & sporting goods applications, by geography & even in-depth by regions. In addition, the study also analyzes the supply chain, raw material supply, cost structure, regulatory issues, patents, and competitive structure of the market.

We have used numerous secondary sources such as encyclopedia, directories, technical magazines, excerpts from conferences, and databases to identify and collect information useful for this extensive technical and commercial study of carbon fiber industry. The primary sources – selected experts from related industries and selected suppliers have been interviewed to obtain and verify critical information as well as to assess the future prospects.

This report focuses on the carbon fiber market and categorizes the global carbon fiber market on the basis of types, applications, and geography:

On the basis of types:

• PAN-based

• Small-tow

• Large-tow

• Pitch-based

• Rayon-based

On the basis of applications:

• Aerospace

• Wind Energy

• Automotive

• Sporting goods

• Other new applications

Coal Bed Methane (CBM) Market by Technology, Geography, Application, Regulation, Market Trends & Global Forecasts (2011 – 2021)

Published: August 2011
No. of Pages: 213
Price: $ 4650



 

Coal bed methane (CBM) is an unconventional natural gas found adsorbed in coal seams. It is primarily extracted from bituminous and sub-bituminous coals. The gas is stored in the coal matrix through adsorption. Coal seam methane can be extracted before, during, or after coal mining operations take place; based on which it can be classified as CBM, coal mine methane (CMM) or abandoned mine methane (AMM). In this report Coal bed methane market, we have only covered CBM. In Australia, the methane thus extracted is called coal seam gas (CSG). The top six countries with the largest CBM resources are Russia, China, U.S., Canada, Indonesia, and Australia.

CBM can be used as a substitute for conventional natural gas in a wide variety of consumer and industrial applications. The porosity of coal bed reservoirs is usually very small, ranging from 0.1 to 10%. Coal bed methane is used to heat homes, propel vehicles, generate electricity and as feedstock in industries, such as for the manufacture of ethylene. The widely used technology for CBM production is multistage hydraulic fracturing combined with horizontal drilling. The report covers the trends and forecasts for 2009-2011, 2016 and 2021 in terms of production and consumption of CBM, along with production costs and average selling prices, and regulations affecting the sector in key geographies. As of 2010, CBM is mostly exploited in North America and Australia, with pilot production planned in China, India, and Indonesia.

Browse All: Energy Market

Currently, horizontal drilling, combined with hydraulic fracturing is the predominant technology used for CBM extraction. The combination of these technologies has played a key role in increasing the production of unconventional gas in North America. However, some concerns have been raised regarding these technologies. A typical CBM well utilizes about thousands of gallons of water per day, and a CBM well’s life can be as long as 50 years. In addition, the water used in the hydraulic fracturing is said to contain chemical additives; which may sometimes leach into underground water resources through permeable rock pores. The fracturing fluid injected into deep rock formations may sometimes return to the surface. Such fluids may contain significant amounts of hazardous chemicals, including benzene, toluene, and glycol ethers, which can cause health disorders.

Total costs of the well vary with geologic rock formations and depth of the coal seam. Enhanced Coal Bed Methane (ECBM, currently in the pilot testing phase) could affect CBM economics by enhancing methane flow and providing operators an opportunity to earn carbon credits.

This report estimates the CBM market size in terms of volumes and value. The market has been further segmented on the basis of applications such as commercial, and industrial, as well as by technologies such as hydraulic fracturing and horizontal drilling. The details are given for major regions and key countries in those regions. Market drivers, restraints, challenges, and opportunities and challenges have been discussed in detail. Market players are also entailed in the report. We have also profiled leading players of this industry including BG Group, Origin Energy, Santos, and others.

 

Biochips Market (DNA Microarrays, Lab-on-Chip, Protein Microarrays, Tissue & Cell Arrays) Trends & Global Forecast (2010-2015)

Published: August 2011
No. of Pages: 278
Price: $ 4650









 

A biochip is defined as a collection of miniaturized test sites (microarrays) arranged on a solid platform that allows multiple tests to be performed at the same time with increased efficiency and higher speed. The global biochip market is studied by the types and key applications. It was valued at $2.6 billion in 2010 and is expected to reach $5.6 billion by 2015; growing at a CAGR of 16.7%. This growth is attributed to increasing applications in cancer diagnostics and expression profiling, the boom in personalized medicine, and government funding.

DNA microarrays represent the largest segment of this market and will continue to be the largest contributor during the study period (2010-2015). However, this segment will be closely followed by lab-on-chip (LOC) in the coming years due to its wide applications and increased adoption by various biotechnology, pharmaceutical companies, and research laboratories. The third largest segment – protein microarrays will be the fastest growing segment; forecasted to grow at a CAGR of 19.9% during the study period due to advances in the fields of genomics and proteomics and improvements in the field of recombinant proteins.

Reverse phase protein microarrays designed for targeted therapies in cancer holds promise in the global biochips market in the next 5-10 years. These microarrays provide increased accuracy and enhanced efficacy for the detection of rare molecules as compared to existing microarray surfaces for cancer research & diagnosis to help understand the proteins in tumor cells. Thus, they have helped open the avenues for personalized methods for cancer therapy.

The market of Asia will account for a bulk of the future biochip market growth due to its high growth potential and huge demand from emerging economies such as India and China - the large pool of heterogeneous patient population, and increasing R&D investment in these countries. The top players in the biochip market such as Affymetrix, Inc., Illumina, Inc., and Fluidigm Corporation have relocated their manufacturing base to Singapore to take advantage of the benefits the country offers; coupled with rising demand from neighboring countries of Asia. The players also benefit from a well-established semiconductor manufacturing base including chip technologies. Singapore has made focused efforts to attract life sciences corporates with dedicated investments accounting for 3% of the country's GDP. It came up with its R&D center - Singapore's Biopolis R&D center in 2003-2004 and is home to the Genome Institute of Singapore.

Scope of the report

This research report categorizes the global biochips market on the basis of applications, types, and geography; forecasting revenues and analyzing trends in each of the following submarkets:

On the basis of applications:

DNA applications: Gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, agricultural biotechnology, drug discovery, and others.
Lab on chip applications: Drug discovery, genomics, diagnostics, proteomics, IVD & POC, high throughput screening, and others.
Protein microarray applications: Expression profiling, proteomics, high throughput screening, diagnostics, drug discovery, and others.
Other array applications: Expression profiling, cancer diagnostics, toxicogenomics, genomics, drug discovery, and others.

On the basis of types:
DNA microarrays, lab on chip, protein microarrays, other arrays (cell arrays and tissue arrays)

On the basis of geography:

North America, Europe, Asia, and Rest of the World.

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. It will also provide market tables for covering the sub-segments. In addition, the report will throw light on more than 20 company profiles covering all the sub-segments.

Global Radiopharmaceuticals Market (PET/SPECT Imaging & Therapy) – Current Trends & Forecasts (2010 – 2015)

Published: August 2011
No. of Pages: 263
Price: $ 4650








Radiopharmaceuticals Therapy and PET/SPECT Imaging – A Global Scenario (2010-2015)

Radiopharmaceuticals are pharmaceutical agents used to diagnose certain medical problems such as cardiac, cancer, neurology, and/or treat certain conditions such as cancers. The use of radiopharmaceuticals as tracer dates back to 1930’s. Over the years, technical advancement in production, diagnostic equipments (SPECT and PET), and discovery of new radiopharmaceutical have driven the market. The global radiopharmaceuticals market for therapy and PET & SPECT imaging was valued at $3,213 million in 2010 and is expected to reach $4,734 million by 2015; growing at a CAGR of 8.1% from 2010 to 2015. The PET & SPECT diagnosis accounted for the largest share -90%- of the global radiopharmaceutical market.

Diagnostic applications of radiopharmaceuticals have around 90% of the market share. The market is growing due to the increasing incidences of cancer and cardiac diseases, requisition of better imaging techniques for diseases such as Alzheimer’s. Targeted alpha therapy is one of the most promising treatments for cancer, which is being researched upon by cancer institutes.

Browse All: Pharmaceuticals Market


Driven by the increasing incidence of cardiac and cancer diseases, early and accurate diagnosis, increasing awareness amongst the masses, and expanding application segment; the global radiopharmaceutical market reached around $3.2 billion in 2010. Radiopharmaceuticals are used for the diagnosis and treatment of various ailments such as cancer, cardiac, renal, and respiratory diseases among the others. PET machines enable radiologists in early detection of cancer, cardiac, and Alzheimer’s disease among the patients. This would increase the demand for PET machines among the healthcare centers and providers. Similarly, SPECT scanners have been on the forefront to bring about significant changes in the diagnostic imaging equipment landscape with opportunities in the market for neuroendocrine tumor imaging. For diagnostic applications of radiopharmaceuticals, radioisotopes such as FDG for PET and technetium for SPECT are most commonly used.

PET and SPECT scans provide dynamic images of the body’s interior, rather than just the bones, like X-ray and magnetic resonance imaging (MRI). PET scan lets the doctor identify glucose metabolism in different parts of the body in a patient. Cancer cells grow at a faster rate than the other cells. The machine detects the speed of glucose being used and indicates the presence of cancerous tumors. The cancerous cell breaks down glucose at a higher rate than the other cells and this increased activity can be seen in a scan. Thus, the use of PET and SPECT scans facilitates early and accurate diagnosis of diseases such as cancer. Increased usage of PET & SPECT scans in turn increases the demand for radiopharmaceuticals.

FDG is the major radiopharmaceutical used in PET (approximately 90%). PET procedures are preferred over SPECT as PET is more accurate, sensitive, and endowed with better spatial arrangement of the image. Besides, the main radiopharmaceutical used in SPECT; i.e. technetium (99m) has a limited supply, forcing people to look for alternatives. FDG can be produced at desired levels to meet all the imaging requirements. This situation is boosting the FDG market.

Most of the radiopharmaceuticals are used in hospitals; accounting for 92%. Majority of the radiopharmaceuticals are administered intravenously. The market for radiopharmaceuticals is restricted by their high cost and difficulties faced while transporting them.

Scope of the report

This research report categorizes the radiopharmaceuticals therapy and PET/SPECT imaging market on the basis of isotopes, routes of administration, applications, and geography; forecasting revenue, and analyzing trends in each of the following submarkets:

On the basis of isotopes:

Fludeoxyglucose (F18), Technetium (Tc99m), Gallium (Ga67), Sodium Iodide (I123), Iobenguane (I131), Rhenium (Re186), Samarium (Sm153),Thallium (Tl201), Yttrium (Y90), Erbium(Er169), and others

On the basis of routes of administration:
Intravenous, peroral, inhalation, and others

On the basis of applications:

Diagnosis (PET and SPECT), indication for diagnosis, and therapy
On the basis of geography:
North America (U.S. and Canada), Europe, Asia-Pacific, Japan, and Rest of the World

Each section provides market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments. In addition, the report provides more than 16 company profiles covering all the sub-segments

World Healthcare IT Market: Trends & Forecast (2010 – 2015)

Published: August 2011
No. of Pages: 279
Price: $ 4650










The world healthcare IT market is expected to grow from $99.6 billion in 2010 to $162.2 billion in 2015, at a CAGR of 10.2% from 2010 to 2015.

Need to cut healthcare costs, enhance clinical/administrative workflow of hospitals, and huge demand for faster, error-free, efficient healthcare delivery, is fueling the healthcare provider IT market worldwide. Furthermore, the initiatives taken by the government for adoption of healthcare IT systems globally are also a significant driving force. Some of the major initiatives expected to hugely impact the market are the U.S Healthcare reforms and ARRA incentives.

EMR is expected to the highest growing market with a CAGR of 16.7% from 2010 to 2015. CPOE is also a fast growing segment with a CAGR of 16.5% from 2010 to 2015. Point of care information systems, specialty care information systems (cardiovascular information systems, oncology information systems), surgical and intensive care information systems are expected to have a combined CAGR of 15.1% from 2010 to 2015.

Browse All: Medical Devices Marke

Low cost IT solutions, financing programs, and interoperable solutions are the focus of top healthcare IT solution providers. With rising adoption of healthcare IT, healthcare delivery models are expected to evolve from clinic centric to patient centric models such as preventive healthcare, remote patient monitoring, telemedicine, and home healthcare. Healthcare industry has always faced immense need for cutting edge technology for patient treatments and monitoring. However, the industry has been slow in adopting IT technologies in their workflow. The scenario is nevertheless changing now, with greater need to cut healthcare costs, immense demand for faster, better healthcare delivery along with reduced medical errors. Healthcare IT enhances clinical and administrative workflow and thus is increasingly being used as a strategy to reduce operating costs and improves the efficiency of healthcare delivery. Healthcare IT systems come across as a cost effective solution for augmenting the clinical and administrative workflow of healthcare providers.

The significant increase in demand for medical care has also increased the chances of error in diagnosis and claim settlement. This has lead to the introduction of systems such as CPOE (computerized physician order entry systems), integrated systems such as enterprise-wide PACS (picture archive and communication systems), EMR (electronic medical record). These not only helped reduce medical errors, but also helped improve the management of health related information.

Understanding the healthcare industry structure can help in gaining an insight into the changing needs of its affiliated IT market. The healthcare industry consists of three major participants – the providers, the payors, and the consumers. As the overall industry is moving towards integration, an insight into each participant’s needs could help system providers design overarching systems that simultaneously cater to all the unmet requirements. Healthcare providers consist of large to small hospitals, clinics, nursing homes, research/educational institutions, and independent physicians. Payors consist of various government and non-government organizations offering insurance policies and claim processing services. Finally, consumers include patients maintaining their medical data.

Meditech (U.S.), Cerner Corporation (U.S.), Mckesson Corporation (U.S.), Siemens Healthcare (Germany), Epic Systems (U.S), Allscripts (U.S.), Philips (The Netherlands), and GE Healthcare (U.S.) account for the majority of the market.

Scope of the report

This research report evaluates the world healthcare IT market with respect to the product market. The report analyzes geography; forecasting revenues, and trends in each of the following submarkets:

Hardware
Software
Services
Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for covering the sub-segments and micro-markets. In addition, company profiles covering all the sub-segments will be given.